en
Connect Learn Finance

Redirect notice

You are being redirected to the platform Enko where you can access 100% free resources to boost your business. This is a collaboration between Visa and Connectamericas for Women.
Home > Companies > Lutris Pharma
Company

Lutris Pharma

To rate this company
Israel
1-10 employees
Established in 2015

Company description

See translation

Lutris Pharma is developing the topical B-Raf inhibitor LUT014, a proprietary small molecule allowing administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects. ...
IndustrySector / Industry
{{industry.name}}
Products and ServicesProducts and Services
{{pas.productName}}
HS code: {{pas.hsCode | limitTo: 23}}
Show more

Commercial information

Affiliations:

Start-Up Nation Central

Badges

These badges certify that certain information declared by a company has been verified, so it can increase the reliability and visibility of its profile.

Find out more!
Company verified byConnectAmericas
What does this badge mean?

ConnectAmericas has verified this company is legally constituted and the people linked to this enterprise are able to do businesses.

Request it!
Find out more about the Badges in ConnectAmericas
This information is provided by Start-Up Nation Finder Click here to see more

Contact information

To see this content

People in this company (1)

Other users also viewed

Loading...

Sign In to ConnectAmericas

Forgot your password? -  Don't have an account? Register here

By creating an account with ConnectAmericas you are accepting
the Privacy Policy and the Terms and Conditions

Enter the e-mail you used when you registered for ConnectAmericas to create a new password